Column Group Opportunity Iii, Lp
10% Owner at Eikon Therapeutics, Inc. (EIKN)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return-31.6%
vs. S&P 500-38.4%
Beat the market0%
Paper profit on buys−$22.3M
Total bought / sold$38.1M / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Feb 9SEC | EIKNEikon Therapeutics, Inc. | Buy | 1,437,3234,312,139 held (+50%) | $18.00 | $25.9M | -58.5% |
| Feb 9SEC | EIKNEikon Therapeutics, Inc. | Buy | 49,556148,840 held (+50%) | $18.00 | $892K | -58.5% |
| Feb 9SEC | EIKNEikon Therapeutics, Inc. | Buy | 630,8811,319,164 held (+92%) | $18.00 | $11.4M | -58.5% |
- Buy
10% Owner Column Group Opportunity Iii, Lp bought $25.9M of EIKN at $18.00 — first open-market purchase in our records; raises the stake by 50%.
- Buy
10% Owner Column Group Opportunity Iii, Lp bought $892K of EIKN at $18.00 — raises the stake by 50%.
- Buy
10% Owner Column Group Opportunity Iii, Lp bought $11.4M of EIKN at $18.00 — raises the stake by 92%.